SCHEMBL2297228

SCHEMBL2297228

CCOC(=O)c1cc(-c2cccc([N+](=O)[O-])c2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.62
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
RAB9A P51151 2/20 0.53
ALDH1A1 P00352 4/20 0.52
MAPK1 P28482 2/20 0.52
SLC6A2 P23975 1/20 0.51
SLC6A4 P31645 1/20 0.51
SLC6A3 Q01959 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
PDE4B Q07343 2/20 0.47
PDE4D Q08499 2/20 0.47
CACNA1F O60840 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CACNA1D Q01668 1/20 0.47
CACNA1S Q13698 1/20 0.47
CACNA1C Q13936 1/20 0.47
PDE4A P27815 1/20 0.46
PDE4C Q08493 1/20 0.46
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2296719 0.87 RAB9A (0.54) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL11509779 0.86 PPARG (0.48) MAPTRAB9AALDH1A1SMN1; SMN2CACNA1F
SCHEMBL8825286 0.81 ALDH1A1 (0.61) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL2293565 0.81 RAB9A (0.46) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL892695 0.81 SMN1; SMN2 (0.58) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL2296749 0.81 SMN1; SMN2 (0.55) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL2294502 0.80 GSTP1 (0.44) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL6432573 0.79 MAPT (0.65) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL20501792 0.78 MEN1 (0.61) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL22347716 0.78 KEAP1 (0.55) MAPTMEN1KMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835428-B2 Diacylglycerol acyltransferase inhibitors Piramal Enterprises Limited (IN) 2014-09-16 US disclosed
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED. 2011-08-11 US disclosed
WO-2010023609-A1 OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS DGAT1, DGAT2, DLAT MAPT 1278/4885MEN1 4530/4885KMT2A 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.